February 07, 2013
Interesting article on Manufacturing Executive:
“Historically, pharma and biotech companies have been far more willing to invest in new drug discovery and development than in improving the antiquated, batch-oriented processes that still tend to dominate the industry.”
Looks like BioTech is chasing improvements in production processes that, they say, could allow them to cut manufacturing costs, vastly improve agility, and avoid shortages.
We are at the forefront of machine design creating machines that research and apply biotechnology in a commercial environment.